학술논문
Updated Phase 1 results from the PYNNACLE Phase 1/2 study of PC14586, a selective p53 reactivator, in patients with advanced solid tumors harboring a TP53 Y220C mutation
Document Type
Journal
Author
Source
Subject
Language
English
ISSN
15388514